C/EBPβ protein and DNA binding activity are increased in cardiac hypertrophy, and downregulation of C/EBPβ attenuates phenylephrine (PE)-induced cardiomyocyte hypertrophy 9, 10. This evidence concerns the gene CEBPB and cardiac hypertrophy.